Search Results - Arpita Pemmaraju

  • Showing 1 - 3 results of 3
Refine Results
  1. 1
    INTRAPLEURAL FIBRINOLYSIS WITH UROKINASE VERSUS ALTEPLASE IN COMPLICATED PLEURAL EFFUSIONS AND EMPYEMA: A PROSPECTIVE RANDOMIZED CONTROLLED TRIAL

    INTRAPLEURAL FIBRINOLYSIS WITH UROKINASE VERSUS ALTEPLASE IN COMPLICATED PLEURAL EFFUSIONS AND EMPYEMA: A PROSPECTIVE RANDOMIZED CONTROLLED TRIAL by Adhikari, Sudipt, Marwah, Vikas, Choudhary, Robin, Pandey, I M, Kumar, Tentu Ajai, Malik, Virender, Pemmaraju, Arpita, V, Shrinath, Kapoor, Suraj

    Get full text
    Items that this one cites
    Article
    Save to List
    Saved in:
  2. 2
    Real-world experience of monoclonal antibodies in mild-to-moderate COVID-19 patients at a tertiary care center

    Real-world experience of monoclonal antibodies in mild-to-moderate COVID-19 patients at a tertiary care center by Marwah, Vikas, Choudhary, Robin, Adhikari, Sudipt, Pemmaraju, Arpita, Menon, A.S., Manrai, Manish, Ajai Kumar, Tentu, Verma, Shipra

    Get full text
    Items that this one cites
    Article
    Save to List
    Saved in:
  3. 3
    Intrapleural Fibrinolysis with Urokinase versus Alteplase in Complicated Pleural Effusions and Empyema: A Prospective Randomized Controlled Trial

    Intrapleural Fibrinolysis with Urokinase versus Alteplase in Complicated Pleural Effusions and Empyema: A Prospective Randomized Controlled Trial by Sudipt Adhikari, Vikas Marwah, Robin Choudhary, Indermani Pandey, Tentu Ajai Kumar, Virender Malik, Arpita Pemmaraju, Shrinath Vasudevan, Suraj Kapoor

    Get full text
    Article
    Save to List
    Saved in:

Search Tools: